Tags

Type your tag names separated by a space and hit enter

Montelukast treatment of urticaria.
Ann Pharmacother. 2006 May; 40(5):939-42.AP

Abstract

OBJECTIVE

To review clinical trial data to determine the benefits of using montelukast alone or as combination therapy in the treatment of urticaria.

DATA SOURCES

MEDLINE (1966-March 2006) and International Pharmaceutical Abstracts (1970-October 2005) were searched to find clinical trial publications that addressed the use of montelukast in urticaria.

DATA SYNTHESIS

Six clinical trials were identified. Montelukast was compared alone and as combination therapy with nonsedating histamine1-receptor antagonists to determine efficacy and safety. Patients had chronic or physical urticaria. The results were mixed. Some studies demonstrated that montelukast can decrease urticarial symptoms with minimal adverse effects, while others found no differences.

CONCLUSION

Large-scale, controlled trials are needed to determine which patients would likely benefit from treatment with montelukast.

Authors+Show Affiliations

College of Pharmacy, Xavier University of Louisiana, New Orleans, LA 70125-1098, USA. tmcbayne@xula.eduNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

16670370

Citation

McBayne, Tyrone O., and O'Rita M. Siddall. "Montelukast Treatment of Urticaria." The Annals of Pharmacotherapy, vol. 40, no. 5, 2006, pp. 939-42.
McBayne TO, Siddall OM. Montelukast treatment of urticaria. Ann Pharmacother. 2006;40(5):939-42.
McBayne, T. O., & Siddall, O. M. (2006). Montelukast treatment of urticaria. The Annals of Pharmacotherapy, 40(5), 939-42.
McBayne TO, Siddall OM. Montelukast Treatment of Urticaria. Ann Pharmacother. 2006;40(5):939-42. PubMed PMID: 16670370.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Montelukast treatment of urticaria. AU - McBayne,Tyrone O, AU - Siddall,O'Rita M, Y1 - 2006/05/02/ PY - 2006/5/4/pubmed PY - 2006/8/1/medline PY - 2006/5/4/entrez SP - 939 EP - 42 JF - The Annals of pharmacotherapy JO - Ann Pharmacother VL - 40 IS - 5 N2 - OBJECTIVE: To review clinical trial data to determine the benefits of using montelukast alone or as combination therapy in the treatment of urticaria. DATA SOURCES: MEDLINE (1966-March 2006) and International Pharmaceutical Abstracts (1970-October 2005) were searched to find clinical trial publications that addressed the use of montelukast in urticaria. DATA SYNTHESIS: Six clinical trials were identified. Montelukast was compared alone and as combination therapy with nonsedating histamine1-receptor antagonists to determine efficacy and safety. Patients had chronic or physical urticaria. The results were mixed. Some studies demonstrated that montelukast can decrease urticarial symptoms with minimal adverse effects, while others found no differences. CONCLUSION: Large-scale, controlled trials are needed to determine which patients would likely benefit from treatment with montelukast. SN - 1060-0280 UR - https://www.unboundmedicine.com/medline/citation/16670370/Montelukast_treatment_of_urticaria_ L2 - https://journals.sagepub.com/doi/10.1345/aph.1G006?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -